Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000213393 is a pseudogene that shares sequence similarity to part of the ribosomal protein L19 (RPL19). Pseudogenes are non-functional segments of DNA resembling functional genes but generally do not encode active proteins or have known biological functions. ENSG00000213393 is not a protein-coding gene, is not classified as a conventional molecular target (such as a receptor, enzyme, transporter, etc.), and does not have known roles in disease, drug interaction, or biomarker use[1][3][5]. Notes: - There is no evidence from current databases that this pseudogene is a therapeutic target or an active coding gene[5]. - The name and entry are accurate for a processed pseudogene, not an active or druggable target. - This entry should not be used as a canonical therapeutic target due to its pseudogene nature[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of ribosomal protein L19.